PRESERVATION OF CHOLINERGIC ACTIVITY AND PREVENTION OF NEURON DEATH BY CEP-1347 KT-7515 FOLLOWING EXCITOTOXIC INJURY OF THE NUCLEUS BASALISMAGNOCELLULARIS/
Ms. Saporito et al., PRESERVATION OF CHOLINERGIC ACTIVITY AND PREVENTION OF NEURON DEATH BY CEP-1347 KT-7515 FOLLOWING EXCITOTOXIC INJURY OF THE NUCLEUS BASALISMAGNOCELLULARIS/, Neuroscience, 86(2), 1998, pp. 461-472
We have identified a class of small organic molecules, derived from th
e indolocarbazole K-252a, that promote the survival of cultured neuron
s. However, many of these indolocarbazoles inhibit protein kinase C an
d neurotrophin-activated tyrosine kinase receptors. These kinase inhib
itory activities may limit the utility of these compounds for neurolog
ical disorders. A bis-ethyl-thiomethyl analogue of K-252a, CEP-1347/KT
-7515, has been identified that lacks protein kinase C and tyrosine ki
nase receptor inhibitory activities, yet retains the ability to promot
e survival of cultured neurons, including cholinergic neurons derived
from the basal forebrain. In the present studies, CEP-1347/KT-7515 was
assessed for neurotrophic activity on basal forebrain neurons of in v
ivo rats following excitotoxic insult. Ibotenate infusion into the nuc
leus basalis magnocellularis reduced levels of choline acetyltransfera
se activity in the cortex, as well as reduced numbers of choline acety
ltransferase-immunoreactive and retrogradely (FluoroGold)-labelled cor
tically-projecting neurons in the nucleus basalis. Systemically admini
stered CEP-1347/KT-7515 attenuated the loss of cortical choline acetyl
transferase activity and the loss of the number of choline acetyltrans
ferase-immunoreactive and retrogradely-labelled FluoroGold neurons in
the nucleus basalis. Moreover, CEP-1347/KT-7515 ameliorated the loss o
f cortical choline acetyltransferase if administration was initiated o
ne day, but rot seven days post-lesion. Together, these results demons
trate that CEP-1347/KT-7515 protects damaged cortically-projecting bas
al forebrain neurons from degeneration. Thus, CEP-1347/KT-7515 may hav
e therapeutic potential in neurodegenerative diseases, such as Alzheim
er's disease, in which basal forebrain cholinergic neurons degenerate.
(C) 1998 IBRO. Published by Elsevier Science Ltd.